Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-03-27 @ 3:44 AM
Study NCT ID:
NCT07221851
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-10
First Post:
2025-10-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Sponsor:
Ascendis Pharma A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ASND0047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None